bay-k-8644 and phenylephrine

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atrial Function; Barium; Cadmium; Calcium; Calcium Channels; Cells, Cultured; Dose-Response Relationship, Drug; Heart Atria; Isoproterenol; Nickel; Nifedipine; Ouabain; Phenylephrine; Propranolol; Rana catesbeiana

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Causality; Cesium; Death, Sudden, Cardiac; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Hemodynamics; Hypertrophy, Left Ventricular; Incidence; Organ Size; Phenylephrine; Prevalence; Tachycardia, Ventricular; Time Factors

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Deferoxamine; Dinoprost; Female; Femoral Artery; Fluorides; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Potassium Chloride; Rabbits; Stress, Mechanical; Time Factors

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Barium; Cadmium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cesium; Epinephrine; Male; Membrane Potentials; Muscle, Smooth, Vascular; Nicardipine; Nickel; Norepinephrine; Phenylephrine; Rats; Rats, Inbred WKY

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Anesthesia, Inhalation; Animals; Azepines; Blood Pressure; Calcium Channel Agonists; Dogs; Female; Halothane; Isoflurane; Male; Phenylephrine

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Adenosine Triphosphate; Animals; Aorta, Thoracic; Calcimycin; Carbachol; Carnitine; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Palmitoylcarnitine; Phenylephrine; Potassium; Rats; Rats, Inbred Strains

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Amiloride; Animals; Biological Transport, Active; Heart Atria; Myocardial Contraction; Ouabain; Phenylephrine; Potassium Channels; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Sodium; Sodium Channels

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Chickens; Colforsin; Drug Interactions; Isoproterenol; Kinetics; Light; Melatonin; Nitrendipine; Norepinephrine; Phenylephrine; Pineal Gland; Receptors, Adrenergic, alpha; Vasoactive Intestinal Peptide; Yohimbine

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adult; Aged; Aged, 80 and over; Aging; Diabetes Complications; Erectile Dysfunction; Humans; In Vitro Techniques; Indomethacin; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Penile Erection; Penis; Phenylephrine; Prazosin; Receptors, Adrenergic, alpha

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Caffeine; Calcimycin; Calcium; Clonidine; Endothelium, Vascular; Endotoxins; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitrendipine; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Animals, Newborn; Bucladesine; Cardiotonic Agents; Cells, Cultured; Colforsin; Heart; Isoenzymes; Isoproterenol; Myocardial Contraction; Myocardium; Myosins; Ouabain; Phenylephrine; Prazosin; Propranolol; Rats

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Clonidine; Daunorubicin; Drug Synergism; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Calcium; Deuterium; Deuterium Oxide; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Water

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Ca(2+) Mg(2+)-ATPase; Calcium Channels; Cell Line, Transformed; Cell Transformation, Viral; Cyclic AMP; Dihydroalprenolol; Embryo, Mammalian; Humans; Isoproterenol; Muscle, Smooth; Phenylephrine; Radioimmunoassay; Receptors, Adrenergic, beta; Simplexvirus; Trifluoperazine

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Cause of Death; Chelating Agents; Coronary Disease; Death, Sudden; Disease Susceptibility; Dogs; Egtazic Acid; Hemodynamics; Muscle Proteins; Myocardium; Phenylephrine; Phosphorylation

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Ammonium Chloride; Animals; Aorta, Thoracic; Drug Synergism; In Vitro Techniques; Kinetics; Male; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Vasoconstriction

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Atrial Natriuretic Factor; Calcium; Calmodulin; Cells, Cultured; Gene Expression; Heart; Hydrolysis; Isoquinolines; Myocardium; Nifedipine; Phenylephrine; Phosphatidylinositols; Piperazines; Protein Kinase C; Rats; Sulfonamides

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Bucladesine; Calcium; Colforsin; In Vitro Techniques; Isoproterenol; Male; Milrinone; Phenylephrine; Phosphodiesterase Inhibitors; Potassium; Pyridones; Quinolones; Rats; Rats, Inbred Strains; Vasodilation

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Electric Stimulation; Endothelins; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Phenylephrine; Phorbol 12,13-Dibutyrate; Rabbits; Signal Transduction; Stimulation, Chemical

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Animals; Calcium; Dioxanes; Dose-Response Relationship, Drug; Female; Heart Conduction System; Heart Rate; Idazoxan; In Vitro Techniques; Labetalol; Methoxamine; Myocardial Contraction; Myocardium; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stimulation, Chemical; Verapamil

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Calcium; Calcium Channel Blockers; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Inbred Strains

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Azepines; Blood Pressure; Brimonidine Tartrate; Cardiac Output; Cats; Dinoprost; Dioxanes; Electric Stimulation; Female; Idazoxan; Male; Methoxamine; Nifedipine; Nisoldipine; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Quinoxalines; Splanchnic Circulation; Sulfonamides; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atropine Derivatives; Azepines; Calcium; Dogs; Female; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Ion Channels; Male; Nifedipine; Phenylephrine; Propranolol; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Receptors, Vasopressin; Vasopressins

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Diabetes Mellitus, Experimental; In Vitro Techniques; Isometric Contraction; Male; Mesenteric Arteries; Methoxamine; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Phenylephrine; Potassium; Rats; Rats, Inbred Strains; Serotonin

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Chloride; Carbachol; Gallopamil; Isoproterenol; Myocardial Contraction; Nifedipine; Phenylephrine; Rabbits

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atropine Derivatives; Blood Pressure; Brain; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Isradipine; Male; Muscarine; Oxadiazoles; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Reflex

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Aorta, Thoracic; Calcium; Carbachol; Diltiazem; Egtazic Acid; Endothelins; Gallopamil; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Peptides; Phenylephrine; Rats; Rats, Inbred Strains; Reference Values; Vasoconstrictor Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Pressure; Calcium; Calcium Channels; Dihydropyridines; Heart Rate; Hypertension; Nifedipine; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Nicotinic; Sympathetic Nervous System

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Calcium; Calcium Channels; Diabetes Mellitus, Experimental; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Phosphatidylinositols; Rats; Rats, Inbred Strains

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Calcium; Calcium Channel Blockers; Clonidine; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Male; Phenylephrine; Rats; Rats, Inbred Strains

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Cold Temperature; Endothelium, Vascular; In Vitro Techniques; Male; Meclofenamic Acid; Nifedipine; Oxygen; Phenylephrine; Pulmonary Artery; Rats; Rats, Inbred Strains; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Calcium; Colforsin; Cyclic AMP; Gallopamil; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Rats; Rats, Inbred Strains

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred SHR; Renin-Angiotensin System

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Calcium; Calcium Channels; Erythrocytes; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Peptides; Phenylephrine; Potassium; Rats; Rats, Inbred Strains

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Azepines; Dose-Response Relationship, Drug; Endothelium; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Ouabain; Phenylephrine; Receptors, Adrenergic, alpha; Serotonin; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Azepines; Calcium; Drug Synergism; In Vitro Techniques; Ion Channels; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Potassium; Rats; Rats, Inbred WKY

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Kinetics; Muscle Contraction; Nifedipine; Nitrendipine; Phenylephrine; Potassium Chloride; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Tritium

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amino Acid Sequence; Animals; Aorta, Thoracic; Calcium; Endothelium, Vascular; In Vitro Techniques; Male; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Peptide Fragments; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Thrombin

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Calcimycin; Calcium; Calcium Channels; Cells, Cultured; Egtazic Acid; Endothelins; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Heart; Inositol Phosphates; Intracellular Fluid; Membrane Lipids; Muscle Proteins; Myocardium; Nifedipine; Ouabain; Phenylephrine; Phosphatidylinositol Diacylglycerol-Lyase; Phosphatidylinositols; Phosphoric Diester Hydrolases; Potassium; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Signal Transduction; Stimulation, Chemical

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Amino Acid Oxidoreductases; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Calcium Channels; Desoxycorticosterone; Dose-Response Relationship, Drug; Drug Implants; Hypertension; Male; Mesenteric Artery, Superior; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Phenylephrine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Stress, Mechanical; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analysis of Variance; Animals; Bradykinin; Endothelins; Heart; In Vitro Techniques; Male; Phenylephrine; Rats; Rats, Wistar; Receptors, Endothelin; Reperfusion Injury; Vasoconstrictor Agents; Vasodilation; Viper Venoms

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Blood Vessels; Calcium Channels; Dose-Response Relationship, Drug; Ganglionic Blockers; Liver Cirrhosis, Experimental; Male; Phenylephrine; Rats; Rats, Sprague-Dawley; Vasopressins

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Carotid Arteries; Cocaine; Diabetes Mellitus, Experimental; Electric Stimulation; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Rabbits; Sympathetic Nervous System; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Dose-Response Relationship, Drug; Enzyme Activation; Femoral Artery; In Vitro Techniques; Ketamine; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Phenylephrine; Phosphatidylinositols; Rabbits; Type C Phospholipases

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Gallic Acid; In Vitro Techniques; Methoxamine; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Potassium Chloride; Rabbits; Receptors, Adrenergic, alpha-1

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta; Calcium; Calcium Channel Agonists; Calcium Channels; Hyperinsulinism; In Vitro Techniques; Insulin Resistance; Ion Channel Gating; Male; Membrane Potentials; Muscle Contraction; Muscle, Smooth, Vascular; Obesity; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Rats, Zucker; Vasodilation

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alprostadil; Animals; Calcium; In Vitro Techniques; Indoles; Male; Muscle Contraction; Phenylephrine; Portal Vein; Rats; Rats, Wistar; Ryanodine; Vasoconstrictor Agents

Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-Antagonists; Analgesics, Opioid; Animals; Calcium; Ceramides; Cyclic AMP; Cyclic GMP; Drug Synergism; Genistein; Isoproterenol; Male; Meperidine; Phenylephrine; Pineal Gland; Potassium; Potassium Chloride; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Calcium; Calcium Channel Agonists; Calcium-Transporting ATPases; Endoplasmic Reticulum; Enzyme Inhibitors; Extracellular Space; Hydroquinones; In Vitro Techniques; Male; Muscle Tonus; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Wistar

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Calcium; Chromans; Endothelium, Vascular; Hypoglycemic Agents; In Vitro Techniques; Insulin; Isometric Contraction; Male; Muscle, Smooth, Vascular; Phenylephrine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Troglitazone; Vasodilator Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Elapid Venoms; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Phenylephrine; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Animals; Aorta, Thoracic; Caffeine; Calcium; Calcium Channel Agonists; Dose-Response Relationship, Drug; In Vitro Techniques; Indole Alkaloids; Indoles; Isoquinolines; Male; Phenylephrine; Potassium; Rats; Rats, Wistar; Sulfonamides; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Calcium Channel Agonists; Cesarean Section; Female; Gestational Age; Glyburide; Humans; Hysterectomy; Methylene Blue; Myometrium; Oxytocin; Phenylephrine; Polyamines; Pregnancy; Spermine; Uterine Contraction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Androstadienes; Animals; Aorta, Thoracic; Calcium; Calcium Channel Agonists; Endothelium, Vascular; Heat-Shock Response; HSP70 Heat-Shock Proteins; Immunoblotting; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myosin Light Chains; Myosin-Light-Chain Kinase; Phenylephrine; Phosphorylation; Potassium Chloride; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Wortmannin

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Drug Interactions; Estradiol; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents

Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Biomarkers; Calcium Channel Agonists; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Cell Differentiation; Cells, Cultured; Diltiazem; Embryonic Stem Cells; Gene Expression Regulation, Developmental; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Phenylephrine; Phosphodiesterase Inhibitors; Propranolol; Time Factors

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Benzopyrans; Caesalpinia; Caffeine; Calcium; Diltiazem; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; In Vitro Techniques; Indenes; Male; Molecular Structure; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nimodipine; Nitric Oxide Synthase; Phenylephrine; Pinacidil; Potassium Chloride; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Aorta, Thoracic; Autonomic Denervation; Blood Pressure; Boron Compounds; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Chloride Channels; Dose-Response Relationship, Drug; Inositol 1,4,5-Trisphosphate Receptors; Male; Membrane Transport Modulators; Nitrobenzoates; Periodicity; Phenylephrine; Rats; Rats, Wistar; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium Channel Blockers; Sodium-Calcium Exchanger; Thapsigargin; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Verapamil

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Adrenergic alpha-Agonists; Amides; Animals; Antihypertensive Agents; Calcium Channel Agonists; Clitoris; Dose-Response Relationship, Drug; Endothelin-1; Female; Isometric Contraction; Models, Animal; Muscle Relaxants, Central; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroprusside; Oligopeptides; Peptides, Cyclic; Phenylephrine; Piperidines; Potassium; Pyridines; Rabbits; Urinary Bladder, Overactive; Vasodilator Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bosentan; Calcium Channel Agonists; Dose-Response Relationship, Drug; Electric Stimulation; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Gap Junctions; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Mesenteric Arteries; Muscle, Smooth, Vascular; Myography; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Paracrine Communication; Phenylephrine; Rats; Rats, Inbred WKY; Receptors, Endothelin; Sulfonamides; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Amides; Animals; Calcium; Dose-Response Relationship, Drug; Drug Synergism; Hydrogen Peroxide; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Muscle, Smooth; Phenylephrine; Pyridines; Rats; Rats, Sprague-Dawley; Time Factors; Urinary Bladder; Verapamil; Vitamin E

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Calcium; GTP-Binding Proteins; Male; Muscle Contraction; Muscle, Smooth; Phenylephrine; Rats; Rats, Wistar; Reperfusion Injury

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic alpha-1 Receptor Agonists; Animals; Benzophenanthridines; Calcium Channel Agonists; Calcium Signaling; Carbenoxolone; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Endothelium, Vascular; Gap Junctions; In Vitro Techniques; Male; Methacholine Chloride; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Phenylephrine; Pinacidil; Potassium Channels; Protein Kinase C; Protein Kinase Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Riluzole; Ryanodine; Tetraethylammonium; Vasomotor System

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Animals; Aorta, Thoracic; Calcium Chloride; Camphanes; Endothelium, Vascular; Glyburide; Phenylephrine; Potassium Channels; Potassium Chloride; Rats; Tetraethylammonium; Vasodilator Agents

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Biological Products; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Male; Muscle, Smooth, Vascular; Phaeophyceae; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Tetraethylammonium; Vasodilation; Vasodilator Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channels, L-Type; Dihydrotestosterone; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Intracellular Space; Male; Muscle Relaxation; Muscle, Smooth; Phenylephrine; Potassium; Swine; Testosterone; Urinary Bladder; Urothelium; Vasoconstrictor Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-1 Receptor Agonists; Animals; Arteries; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclosporine; Hypertension; Immunosuppressive Agents; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phenylephrine; Protein Kinase C; Rats; Rats, Wistar; Vasoconstriction

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antihypertensive Agents; Blood Pressure; Caffeine; Calcium; Calcium Chloride; Calcium Signaling; Dihydropyridines; Hypotension; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Phenylephrine; Potassium; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Vasoconstriction; Vasodilation; Vasodilator Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic Agonists; Animals; Aorta, Thoracic; Aspidosperma; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Heart Rate; Herb-Drug Interactions; In Vitro Techniques; Male; Phenylephrine; Plant Extracts; Potassium Channel Blockers; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Agonists; Calcium Channels; Calcium Chloride; Endothelium, Vascular; Ethanol; Male; Phenylephrine; Plant Bark; Plant Stems; Potassium Channels; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Wistar; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Zanthoxylum

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Cyclohexane Monoterpenes; Cyclohexenes; Isometric Contraction; Limonene; Molecular Structure; Monoterpenes; Muscle, Smooth, Vascular; Phenylephrine; Phorbol 12,13-Dibutyrate; Rats; Structure-Activity Relationship; Terpenes; Vasodilator Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Dose-Response Relationship, Drug; Intercellular Signaling Peptides and Proteins; Ischemia; Male; Muscle, Smooth, Vascular; Peptides; Phenylephrine; Rats, Wistar; Reperfusion; Reperfusion Injury; Tail; Vasoconstriction; Vasoconstrictor Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Calcium Channel Blockers; Calcium Signaling; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Protein Kinase Inhibitors; Rats; Resveratrol; rho-Associated Kinases